United Kingdom Breast Cancer Screening Market Insight
Published: 03 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The United Kingdom Breast Cancer Screening Market is anticipated to grow at a CAGR of around 6.8% from 2025 to 2035, driven by increasing breast cancer incidence rates, expanding adoption of digital mammography technologies, rising awareness regarding early disease detection, and continued investments in national screening initiatives across the country.
United Kingdom Breast Cancer Screening Market Forecasts to 2035
- The United Kingdom Breast Cancer Screening Market Size was estimated at USD 1.18 Billion in 2025.
- The market is expected to grow at a CAGR of around 6.8% from 2025 to 2035.
- The United Kingdom Breast Cancer Screening Market Size is expected to reach around USD 2.28 Billion by 2035.
Notable Insights for the United Kingdom Breast Cancer Screening Market
- Segmentation based on technology, digital mammography, breast tomosynthesis, ultrasound screening, MRI screening, and AI-enabled imaging solutions collectively accounted for nearly 74% of the market share in 2025, supported by growing emphasis on early diagnosis and improved imaging precision.
- Segmentation based on end user, hospitals, diagnostic imaging centers, breast screening clinics, ambulatory care facilities, and specialty cancer centers represented approximately 72% of the market share in 2025, owing to increased participation in organized breast cancer screening programs.
- The United Kingdom Breast Cancer Screening Market is supported by Hologic, GE HealthCare, and Siemens Healthineers, which reported revenues of approximately USD 4.08 billion, USD 19.67 billion, and USD 24.56 billion, reflecting continued advancements in breast imaging and diagnostic technologies.
Download the eBook (ToC)
- Koninklijke Philips N.V., Fujifilm Holdings Corporation, and Canon Medical Systems generated revenues of approximately USD 19.84 billion, USD 20.13 billion, and USD 4.10 billion respectively, highlighting ongoing investments in digital screening systems and women's healthcare solutions.
Why Buy This Report
- Provides a comprehensive assessment of breast cancer screening trends, diagnostic imaging advancements, and emerging opportunities influencing the United Kingdom healthcare landscape.
- Delivers valuable insights into technology adoption, screening program developments, healthcare infrastructure expansion, and long-term market growth prospects.
- Assists stakeholders in evaluating competitive positioning, strategic initiatives, investment opportunities, and evolving patient screening patterns within the United Kingdom breast cancer diagnostics sector.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom breast cancer screening market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Breast Cancer Screening Market
- Hologic, Inc.
- GE HealthCare
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Fujifilm Holdings Corporation
- Canon Medical Systems Corporation
- ScreenPoint Medical
- Volpara Health Technologies
- Kheiron Medical Technologies
- Metaltronica S.p.A.
Recent Developments:
- In September 2025, Hologic launched an upgraded breast imaging platform integrating artificial intelligence capabilities to improve screening efficiency and support earlier breast cancer detection across healthcare facilities in Europe.
- In May 2025, Kheiron Medical collaborated with NHS screening centers in the United Kingdom to expand deployment of AI-assisted mammography solutions aimed at enhancing diagnostic accuracy and workflow optimization.
Market Segmentation:
United Kingdom Breast Cancer Screening Market, By Technology
- Digital Mammography
- Breast Tomosynthesis
- Breast Ultrasound
- Magnetic Resonance Imaging (MRI)
- AI-Enabled Screening Solutions
- Others
United Kingdom Breast Cancer Screening Market, By End User
- Hospitals
- Diagnostic Imaging Centers
- Breast Screening Clinics
- Ambulatory Care Centers
- Specialty Cancer Centers
- Others
United Kingdom Breast Cancer Screening Market, By Screening Type
- Population-Based Screening
- Opportunistic Screening
- Diagnostic Screening
United Kingdom Breast Cancer Screening Market, By Age Group
- Below 40 Years
- 40–49 Years
- 50–69 Years
- Above 70 Years
Expert Views:
The United Kingdom breast cancer screening market is projected to witness sustained growth through 2035, supported by increasing emphasis on preventive healthcare, rising adoption of advanced mammography technologies, and growing integration of artificial intelligence within diagnostic imaging workflows. Industry participants are focusing on product innovation and strategic collaborations to strengthen their market presence and improve screening outcomes across the country.
Author: Govind and Krishna By Decisions Advisors and Consulting